“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...
The Society for Cardiovascular Angiography and Interventions has released a position statement outlining best practices for transcatheter patent ductus arteriosus (PDA) closure in premature infants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results